Is Silexion Therapeutics Ltd. (SLXN) a Buy, Sell, or Hold?
NASDAQ : SLXN
Silexion Therapeutics Ltd. — Earnings Estimates
$0.4549 USD
-$0.58 (-56.05%)
- Volume
- 3.72M
- Average Volume
- 660.11K
- Market Capitalization
- $190.6K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $80.00
- Year Low
- $0.43
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.00
Annual earnings financials
SLXN financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
SLXN Estimated and Actual Revenue by Quarter
SLXN Estimated and Actual EPS by Quarter
SLXN Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2026-12-31 | 0 | - | - | - | - | - | - |
| 2026-09-30 | 0 | - | - | - | - | - | - |
| 2026-06-30 | 0 | - | - | - | - | - | - |
| 2026-03-31 | 0 | - | - | - | - | - | - |
SLXN Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2026-12-31 | 0 | -2.36M | -2.36M | -2.36M | - | - | - |
| 2026-09-30 | 0 | -4.91M | -4.91M | -4.91M | - | - | - |
| 2026-06-30 | 0 | -6.85M | -6.85M | -6.85M | - | - | - |
| 2026-03-31 | 0 | -4.17M | -4.17M | -4.17M | - | - | - |
SLXN Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2026-12-31 | 0 | - | - | - | 1 | -7.3 | -7.3 | -7.3 |
| 2026-09-30 | 0 | - | - | - | 1 | -15.2 | -15.2 | -15.2 |
| 2026-06-30 | 0 | - | - | - | 1 | -21.2 | -21.2 | -21.2 |
| 2026-03-31 | 0 | - | - | - | 1 | -12.9 | -12.9 | -12.9 |